cancer subtypes Mar 2, 2022 Inherited Cancer Risk Detected in Significant Subset of Wilms Tumor Cases Feb 9, 2022 Large-Scale Cancer Genome Analysis Reveals Mutation Clusters That Can Inform Prognosis Jan 28, 2022 Breast Tumor Features Reflecting Germline Variants May Improve Risk Prediction Models Jan 27, 2022 Certain Childhood ALL Subtypes Linked to Genetic Ancestry Nov 17, 2021 Multiple Myeloma Patient Similarity Network Reveals Prognostically Informative Subgroups Oct 21, 2021 Germline Cancer Risk Genes May Hold Rhabdomyosarcoma Survival Clues, Study Suggests Jun 4, 2021 Breast Cancer Genomics Study Reveals Recurrent Contributors to Treatment Resistance in Early Disease Jan 11, 2021 Glioblastoma Transcriptomes Point to Mitochondrial Subtype, Potential Treatment Strategies Aug 13, 2020 Triple-Negative Breast Cancer Treatment Hints Drawn From Single-Cell Study Jul 29, 2020 Pancreatic Cancer Action Network, GeneCentric Therapeutics Launch Research Partnership Jun 18, 2020 MMRF Taps GNS Healthcare to Analyze Multiple Myeloma Dataset Apr 3, 2020 Breast Cancer Subtypes Vary With Indigenous Ancestry in Latin American Women Sep 10, 2019 Repare Therapeutics Using CRISPR to Develop Cancer Treatments for Synthetic Lethal Targets Premium Jun 2, 2019 CDK4/6 Inhibitor Boosts Overall Survival in Advanced, Premenopausal Breast Cancer Subgroup Premium May 16, 2019 Novartis Seeks FDA OK for Drug With Favorable Phase III Results in PIK3CA-Mutated Breast Cancer May 6, 2019 RB1 Alterations in Advanced Prostate Cancer Associated With Poor Outcome May 2, 2019 Immunotherapy Response in MMR-Deficient Tumors Linked to MSI Levels, Indel Mutations Apr 25, 2019 Colon Cancer Biology, Treatment Clues Found in Proteogenomic Analysis Apr 8, 2019 Proteome Analysis of Five Breast Tumor Subtypes Points to Additional Classifications Jan 3, 2019 Glioblastoma Pathway Signatures, Treatment Responses Differ Between Male, Female Patients Load More Breaking News In Brief This Week: Gilead Sciences, Arcus Biosciences, Verismo Therapeutics, Caris Life Sciences Pyxis Oncology Gets FDA Permission to Start Phase I Trials of Anti-EDB Drug, Immunotherapy FDA Approves Rigel Pharmaceuticals' Rezlidhia for IDH1-Mutant AML Sofie Biosciences to Begin Trial of Fluorine-Labeled PET Diagnostic Imaging Agent for GI Cancers Study Unearths Features Found in Long-Term Survivors of Advanced Ovarian Cancer Carrick Therapeutics Receives $35M Investment From Pfizer; Raises $25M in Series C Funding Round
